Nifty

:

18562.75

Sensex

:

62504.80

50.00 (0.27%)
211.16 (0.34%)

Login

Nifty
Sensex

:
:

18562.75
62504.80

50.00 (0.27%)
211.16 (0.34%)

Divi's Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

50/99

BSE: 532488 | NSE: DIVISLAB

Watchlist

NSE BSE

3375.55

28-Nov-2022

Day's Open
Day's High
Day's Low
Previous Close

3352.00
3385.00
3337.50
3342.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

498592
16799.62
4990.00
3195.15

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

88,708.98
29.59
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

85,890.10
0.90%
7.30

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.37
18.15
18.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.88
25.18
16.31

PAT CAGR (%)

10 Years
5 Years
3 Years

17.27
27.55
29.08

P:E (Median)

8 Years
5 Years
3 Years

33.49
44.37
49.22

P:BV (Average)

8 Years
5 Years
3 Years

7.82
8.59
10.24

EV:EBITDA (Average)

8 Years
5 Years
3 Years

25.50
29.28
32.87

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 1,823.38 1,967.86 -7.34% 2,203.92 1,950.16 13.01% 2,495.03 1,718.39 45.20% 2,466.77 1,656.48 48.92%
Expenses 1,214.12 1,149.27 5.64% 1,366.34 1,098.69 24.36% 1,399.06 1,019.04 37.29% 1,366.87 978.03 39.76%
EBITDA 609.26 818.59 -25.57% 837.58 851.47 -1.63% 1,095.97 699.35 56.71% 1,099.90 678.45 62.12%
EBIDTM 33.41% 41.60% 38.00% 43.66% 43.93% 40.70% 44.59% 40.96%
Other Income 79.25 19.11 314.70% 89.99 35.55 153.14% 50.51 22.85 121.05% 16.62 19.68 -15.55%
Interest 0.13 0.17 -23.53% 0.10 0.24 -58.33% 0.04 0.18 -77.78% 0.20 0.22 -9.09%
Depreciation 85.48 77.09 10.88% 83.42 73.01 14.26% 80.75 69.84 15.62% 79.70 67.95 17.29%
PBT 602.90 760.44 -20.72% 844.05 813.77 3.72% 1,065.69 652.18 63.40% 1,036.62 629.96 64.55%
Tax 116.05 154.05 -24.67% 152.44 261.80 -41.77% 182.73 164.25 11.25% 129.40 168.72 -23.30%
PAT 486.85 606.39 -19.71% 691.61 551.97 25.30% 882.96 487.93 80.96% 907.22 461.24 96.69%
PATM 26.70% 30.81% 31.38% 28.30% 35.39% 28.39% 36.78% 27.84%
EPS 18.34 22.84 -19.70% 26.05 20.79 25.30% 33.26 18.38 80.96% 34.17 17.37 96.72%

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 1,854.54 1,987.51 -6.69% 2,254.52 1,960.64 14.99% 2,518.44 1,788.19 40.84% 2,493.24 1,701.44 46.54%
Expenses 1,233.50 1,169.44 5.48% 1,407.82 1,108.59 26.99% 1,414.02 1,071.93 31.91% 1,396.06 1,010.23 38.19%
EBITDA 621.04 818.07 -24.08% 846.70 852.05 -0.63% 1,104.42 716.26 54.19% 1,097.18 691.21 58.73%
EBIDTM 33.49% 41.16% 37.56% 43.46% 43.85% 40.05% 44.01% 40.63%
Other Income 80.08 19.11 319.05% 88.39 35.97 145.73% 52.39 23.52 122.75% 16.62 19.32 -13.98%
Interest 0.17 0.21 -19.05% 0.13 0.28 -53.57% 0.08 0.21 -61.90% 0.23 0.27 -14.81%
Depreciation 85.73 77.35 10.83% 83.66 73.26 14.20% 80.99 70.08 15.57% 79.91 68.18 17.20%
PBT 615.22 759.62 -19.01% 851.30 814.48 4.52% 1,075.74 669.49 60.68% 1,033.66 642.08 60.99%
Tax 121.62 153.16 -20.59% 149.29 257.37 -41.99% 181.10 167.47 8.14% 131.42 171.46 -23.35%
PAT 493.60 606.46 -18.61% 702.01 557.11 26.01% 894.64 502.02 78.21% 902.24 470.62 91.71%
PATM 26.62% 30.51% 31.14% 28.41% 35.52% 28.07% 36.19% 27.66%
EPS 18.59 22.85 -18.64% 26.45 20.99 26.01% 33.70 18.91 78.21% 33.99 17.73 91.71%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 8,989.10 8,879.82 6,798.61 5,310.57 4,879.66 3,815.94 4,023.85 3,721.33 3,084.01 2,513.97 2,128.89 Net Sales Growth 23.26% 30.61% 28.02% 8.83% 27.88% -5.17% 8.13% 20.67% 22.67% 18.09% Cost Of Goods Sold 3,161.42 2,989.80 2,265.50 2,088.56 1,837.83 1,504.90 1,541.58 1,495.70 1,215.44 918.14 797.66 Gross Profit 5,827.68 5,890.02 4,533.11 3,222.01 3,041.83 2,311.04 2,482.27 2,225.62 1,868.57 1,595.82 1,331.23 GP Margin 64.83% 66.33% 66.68% 60.67% 62.34% 60.56% 61.69% 59.81% 60.59% 63.48% 62.53% Total Expenditure 5,346.39 5,005.05 3,977.73 3,494.16 3,029.59 2,564.33 2,584.97 2,319.91 1,920.97 1,494.24 1,306.36 Power & Fuel Cost - 390.05 319.15 280.73 248.78 228.73 198.80 180.34 170.82 147.40 131.02 % Of Sales - 4.39% 4.69% 5.29% 5.10% 5.99% 4.94% 4.85% 5.54% 5.86% 6.15% Employee Cost - 926.55 808.68 608.36 530.72 446.27 490.33 352.95 283.15 225.43 191.20 % Of Sales - 10.43% 11.89% 11.46% 10.88% 11.69% 12.19% 9.48% 9.18% 8.97% 8.98% Manufacturing Exp. - 336.15 269.24 238.06 189.32 169.16 155.91 159.65 134.82 110.93 96.90 % Of Sales - 3.79% 3.96% 4.48% 3.88% 4.43% 3.87% 4.29% 4.37% 4.41% 4.55% General & Admin Exp. - 211.22 166.34 135.34 97.56 133.03 79.49 67.41 58.68 46.15 40.67 % Of Sales - 2.38% 2.45% 2.55% 2.00% 3.49% 1.98% 1.81% 1.90% 1.84% 1.91% Selling & Distn. Exp. - 107.56 110.21 75.11 62.51 58.37 59.82 50.37 45.83 39.64 47.70 % Of Sales - 1.21% 1.62% 1.41% 1.28% 1.53% 1.49% 1.35% 1.49% 1.58% 2.24% Miscellaneous Exp. - 43.72 38.61 68.00 62.87 23.87 59.04 13.48 12.23 6.55 47.70 % Of Sales - 0.49% 0.57% 1.28% 1.29% 0.63% 1.47% 0.36% 0.40% 0.26% 0.06% EBITDA 3,642.71 3,874.77 2,820.88 1,816.41 1,850.07 1,251.61 1,438.88 1,401.42 1,163.04 1,019.73 822.53 EBITDA Margin 40.52% 43.64% 41.49% 34.20% 37.91% 32.80% 35.76% 37.66% 37.71% 40.56% 38.64% Other Income 236.37 114.03 63.45 189.86 156.58 112.48 75.94 95.92 42.84 83.90 48.51 Interest 0.47 1.73 1.81 7.03 4.61 2.31 3.33 3.94 2.85 2.93 2.56 Depreciation 329.35 310.55 254.65 185.95 168.81 142.42 123.26 118.10 135.85 92.06 76.90 PBT 3,549.26 3,676.52 2,627.87 1,813.29 1,833.23 1,219.36 1,388.23 1,375.29 1,067.18 1,008.64 791.58 Tax 580.62 727.98 673.15 440.58 500.58 349.78 334.96 264.45 220.12 216.92 180.16 Tax Rate 16.36% 19.80% 25.62% 24.30% 27.31% 28.69% 24.13% 19.23% 20.63% 21.51% 22.76% PAT 2,968.64 2,948.54 1,954.72 1,372.71 1,332.65 869.58 1,053.27 1,110.84 847.06 791.72 611.42 PAT before Minority Interest 2,968.64 2,948.54 1,954.72 1,372.71 1,332.65 869.58 1,053.27 1,110.84 847.06 791.72 611.42 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 33.02% 33.20% 28.75% 25.85% 27.31% 22.79% 26.18% 29.85% 27.47% 31.49% 28.72% PAT Growth 40.86% 50.84% 42.40% 3.01% 53.25% -17.44% -5.18% 31.14% 6.99% 29.49% EPS 111.81 111.06 73.62 51.70 50.19 32.75 39.67 41.84 31.90 29.82 23.03

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 9,120.74 8,959.83 6,969.40 5,394.42 4,946.26 3,891.49 4,064.34 3,776.36 3,114.94 2,532.14 2,144.84 Net Sales Growth 22.63% 28.56% 29.20% 9.06% 27.10% -4.25% 7.63% 21.23% 23.02% 18.06% Cost Of Goods Sold 3,156.76 2,967.14 2,324.08 2,108.54 1,825.22 1,534.06 1,534.00 1,505.32 1,213.24 914.15 798.63 Gross Profit 5,963.98 5,992.69 4,645.32 3,285.88 3,121.04 2,357.43 2,530.34 2,271.04 1,901.70 1,617.99 1,346.21 GP Margin 65.39% 66.88% 66.65% 60.91% 63.10% 60.58% 62.26% 60.14% 61.05% 63.90% 62.77% Total Expenditure 5,451.40 5,078.72 4,108.34 3,571.21 3,073.24 2,628.74 2,617.20 2,358.04 1,948.69 1,516.76 1,328.87 Power & Fuel Cost - 392.33 319.15 280.73 248.78 228.73 198.80 180.34 170.82 147.40 131.02 % Of Sales - 4.38% 4.58% 5.20% 5.03% 5.88% 4.89% 4.78% 5.48% 5.82% 6.11% Employee Cost - 946.16 825.76 621.05 542.27 456.06 499.90 361.19 290.42 232.46 197.72 % Of Sales - 10.56% 11.85% 11.51% 10.96% 11.72% 12.30% 9.56% 9.32% 9.18% 9.22% Manufacturing Exp. - 365.92 297.84 258.91 212.96 182.67 169.15 169.42 147.24 121.10 104.85 % Of Sales - 4.08% 4.27% 4.80% 4.31% 4.69% 4.16% 4.49% 4.73% 4.78% 4.89% General & Admin Exp. - 236.44 175.26 148.62 105.30 139.33 88.22 73.91 63.85 51.74 44.15 % Of Sales - 2.64% 2.51% 2.76% 2.13% 3.58% 2.17% 1.96% 2.05% 2.04% 2.06% Selling & Distn. Exp. - 127.01 124.03 85.36 73.08 64.02 67.48 56.04 51.93 44.22 51.29 % Of Sales - 1.42% 1.78% 1.58% 1.48% 1.65% 1.66% 1.48% 1.67% 1.75% 2.39% Miscellaneous Exp. - 43.72 42.22 68.00 65.63 23.87 59.65 11.80 11.18 5.69 51.29 % Of Sales - 0.49% 0.61% 1.26% 1.33% 0.61% 1.47% 0.31% 0.36% 0.22% 0.06% EBITDA 3,669.34 3,881.11 2,861.06 1,823.21 1,873.02 1,262.75 1,447.14 1,418.32 1,166.25 1,015.38 815.97 EBITDA Margin 40.23% 43.32% 41.05% 33.80% 37.87% 32.45% 35.61% 37.56% 37.44% 40.10% 38.04% Other Income 237.48 115.90 62.67 189.63 155.63 113.44 74.89 97.44 44.70 70.60 44.81 Interest 0.61 2.00 2.10 7.14 4.68 2.37 3.36 4.74 2.88 2.96 2.59 Depreciation 330.29 311.51 255.59 186.24 168.90 142.49 123.33 118.18 136.00 92.12 76.95 PBT 3,575.92 3,683.50 2,666.04 1,819.46 1,855.07 1,231.33 1,395.34 1,392.84 1,072.08 990.92 781.24 Tax 583.43 723.05 681.75 442.92 502.33 354.32 334.92 267.06 220.56 217.58 179.23 Tax Rate 16.32% 19.63% 25.57% 24.34% 27.08% 28.78% 24.00% 19.17% 20.57% 21.96% 22.94% PAT 2,992.49 2,960.45 1,984.29 1,376.54 1,352.74 877.01 1,060.42 1,125.78 851.52 773.34 602.01 PAT before Minority Interest 2,992.49 2,960.45 1,984.29 1,376.54 1,352.74 877.01 1,060.42 1,125.78 851.52 773.34 602.01 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 32.81% 33.04% 28.47% 25.52% 27.35% 22.54% 26.09% 29.81% 27.34% 30.54% 28.07% PAT Growth 40.08% 49.19% 44.15% 1.76% 54.24% -17.30% -5.81% 32.21% 10.11% 28.46% EPS 112.71 111.50 74.74 51.85 50.95 33.03 39.94 42.40 32.07 29.13 22.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 11,691.35 9,271.57 7,316.69 6,973.31 5,959.65 5,408.91 4,357.04 3,561.96 3,034.42 2,553.28 Share Capital 53.09 53.09 53.09 53.09 53.09 53.09 53.09 26.55 26.55 26.55 Total Reserves 11,638.26 9,218.48 7,263.60 6,920.22 5,906.56 5,355.82 4,303.95 3,535.41 3,007.87 2,526.73 Non-Current Liabilities 448.11 363.48 294.48 993.72 1,769.95 1,418.95 92.33 847.80 656.71 477.08 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.47 1.05 1.55 2.10 Long Term Provisions 26.71 25.42 20.52 772.54 1,577.26 1,288.92 11.57 714.30 533.49 388.43 Current Liabilities 2,427.29 1,704.78 1,796.64 832.52 640.49 655.84 516.12 772.32 623.14 551.59 Trade Payables 771.30 748.78 580.34 483.31 405.65 442.30 230.42 224.38 148.69 158.31 Other Current Liabilities 392.95 337.25 286.51 242.50 170.79 176.52 239.46 202.73 146.55 129.35 Short Term Borrowings 0.00 0.35 33.63 105.60 63.11 35.74 41.42 25.07 16.32 30.51 Short Term Provisions 1,263.04 618.40 896.16 1.11 0.94 1.28 4.81 320.14 311.58 233.42 Total Liabilities 14,566.75 11,339.83 9,407.81 8,799.55 8,370.09 7,483.70 4,965.49 5,182.08 4,314.27 3,581.95 Net Block 4,320.97 3,699.01 2,776.26 2,087.44 1,995.88 1,558.95 1,438.64 1,308.73 1,221.60 908.50 Gross Block 5,617.69 4,685.46 3,508.06 2,633.29 2,372.92 1,793.57 2,195.42 1,952.40 1,739.79 1,337.88 Accumulated Depreciation 1,296.72 986.45 731.80 545.85 377.04 234.62 756.78 643.67 518.19 429.38 Non Current Assets 5,011.90 4,598.63 3,852.94 4,152.06 3,816.18 3,444.55 1,907.39 2,386.10 2,034.87 1,708.04 Capital Work in Progress 469.93 710.62 919.69 491.91 119.76 443.57 263.91 218.18 144.48 303.41 Non Current Investment 79.37 7.37 7.37 554.62 7.37 8.37 10.19 2.82 2.82 2.82 Long Term Loans & Adv. 133.58 172.42 144.18 1,012.93 1,688.04 1,424.88 188.87 856.03 665.87 493.23 Other Non Current Assets 8.05 9.21 5.44 5.16 5.13 8.78 5.78 0.35 0.09 0.07 Current Assets 9,554.85 6,741.20 5,554.87 4,647.49 4,553.91 4,039.15 3,058.10 2,795.98 2,279.41 1,873.91 Current Investments 0.00 0.00 971.35 1,398.34 1,889.29 1,630.72 802.85 733.00 501.88 407.81 Inventories 2,644.05 2,042.70 1,744.17 1,663.18 1,281.39 1,255.76 1,162.89 1,114.90 893.27 805.95 Sundry Debtors 2,569.90 1,745.56 1,533.21 1,282.24 1,112.11 1,002.89 966.12 823.03 791.64 558.90 Cash & Bank 2,803.68 2,142.01 107.36 105.20 91.48 66.47 59.38 56.66 35.77 34.68 Other Current Assets 1,537.22 51.63 48.63 11.56 179.64 83.31 66.86 68.39 56.86 66.56 Short Term Loans & Adv. 1,507.86 759.30 1,150.15 186.97 160.15 63.14 48.19 54.14 47.56 57.28 Net Current Assets 7,127.56 5,036.42 3,758.23 3,814.97 3,913.42 3,383.31 2,541.98 2,023.66 1,656.26 1,322.32 Total Assets 14,566.75 11,339.83 9,407.81 8,799.55 8,370.09 7,483.70 4,965.49 5,182.08 4,314.28 3,581.95

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 11,728.18 9,294.61 7,309.92 6,957.15 5,924.80 5,357.39 4,293.31 3,495.36 2,963.35 2,500.60 Share Capital 53.09 53.09 53.09 53.09 53.09 53.09 53.09 26.55 26.55 26.55 Total Reserves 11,675.09 9,241.52 7,256.83 6,904.06 5,871.71 5,304.30 4,240.21 3,468.81 2,936.80 2,474.05 Non-Current Liabilities 436.51 363.94 294.57 991.38 1,768.91 1,411.75 85.17 841.57 650.05 469.75 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.47 1.05 1.55 2.10 Long Term Provisions 26.71 25.42 20.52 772.54 1,577.26 1,288.92 11.57 714.30 533.49 388.43 Current Liabilities 2,454.44 1,728.35 1,820.53 846.75 653.42 659.45 519.50 775.53 627.41 554.45 Trade Payables 795.70 763.20 590.72 492.26 411.21 445.80 232.69 226.87 151.70 160.44 Other Current Liabilities 394.02 340.42 290.09 243.59 175.46 176.63 240.58 203.45 147.80 130.08 Short Term Borrowings 0.00 0.35 33.63 105.60 63.11 35.74 41.42 25.07 16.32 30.51 Short Term Provisions 1,264.72 624.38 906.09 5.30 3.64 1.28 4.81 320.14 311.58 233.42 Total Liabilities 14,619.13 11,386.90 9,425.02 8,795.28 8,347.13 7,428.59 4,897.98 5,112.46 4,240.81 3,524.80 Net Block 4,325.05 3,703.87 2,781.85 2,087.77 1,996.19 1,559.19 1,438.77 1,308.89 1,221.84 908.72 Gross Block 5,624.27 4,691.86 3,514.25 2,633.93 2,373.45 1,793.95 2,196.08 1,953.02 1,740.34 1,338.35 Accumulated Depreciation 1,299.22 987.99 732.40 546.16 377.26 234.76 757.32 644.13 518.50 429.63 Non Current Assets 5,008.74 4,596.30 3,851.49 4,145.23 3,812.01 3,418.08 1,870.93 2,340.06 1,984.45 1,660.69 Capital Work in Progress 469.93 710.62 919.69 491.91 119.76 443.57 263.91 218.18 144.48 303.41 Non Current Investment 72.01 0.01 0.01 547.26 0.01 0.01 0.01 0.00 0.00 0.00 Long Term Loans & Adv. 133.70 172.59 144.50 1,012.93 1,688.23 1,406.48 162.44 812.63 618.03 448.49 Other Non Current Assets 8.05 9.21 5.44 5.36 7.82 8.83 5.80 0.35 0.09 0.07 Current Assets 9,610.39 6,790.60 5,573.53 4,650.05 4,535.12 4,010.51 3,027.04 2,772.40 2,256.35 1,864.11 Current Investments 0.00 0.00 971.35 1,398.34 1,889.28 1,630.72 802.85 733.00 501.88 407.81 Inventories 2,828.62 2,145.23 1,863.86 1,772.34 1,350.67 1,319.91 1,207.83 1,162.64 932.42 835.69 Sundry Debtors 2,423.88 1,676.52 1,413.35 1,163.37 1,014.36 900.92 880.92 741.64 723.70 512.00 Cash & Bank 2,818.88 2,156.03 122.63 115.26 112.46 78.70 73.43 65.22 40.51 40.89 Other Current Assets 1,539.01 51.95 52.16 142.20 168.35 80.26 62.01 69.89 57.85 67.71 Short Term Loans & Adv. 1,509.32 760.87 1,150.18 58.54 43.37 59.59 42.88 54.98 48.16 57.97 Net Current Assets 7,155.95 5,062.25 3,753.00 3,803.30 3,881.70 3,351.06 2,507.54 1,996.87 1,628.95 1,309.66 Total Assets 14,619.13 11,386.90 9,425.02 8,795.28 8,347.13 7,428.59 4,897.97 5,112.46 4,240.80 3,524.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 1,910.16 1,947.05 1,208.47 964.06 764.72 1,149.11 1,036.34 822.44 558.15 482.83 PBT 3,676.52 2,627.87 1,813.29 1,833.23 1,219.36 1,388.23 1,375.29 1,067.18 1,008.64 791.58 Adjustment 235.32 186.66 52.55 86.71 29.72 81.10 69.27 108.33 70.06 55.01 Changes in Working Capital -1,371.89 -234.52 -211.40 -472.96 -215.81 -18.52 -147.34 -141.64 -307.22 -189.31 Cash after chg. in Working capital 2,539.95 2,580.01 1,654.44 1,446.98 1,033.27 1,450.81 1,297.23 1,033.87 771.48 657.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -629.79 -632.96 -445.97 -482.92 -268.55 -301.70 -260.89 -211.43 -213.34 -174.46 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,195.40 75.34 -81.38 -684.24 -475.89 -1,137.41 -411.16 -520.77 -305.08 -254.49 Net Fixed Assets -691.54 -968.33 -1,302.55 -632.52 -255.54 222.19 -288.75 -286.31 -242.98 -368.08 Net Investments -72.00 971.35 974.24 -56.30 -257.57 -826.05 -77.22 -231.12 -94.07 69.23 Others -1,431.86 72.32 246.93 4.58 37.22 -533.55 -45.19 -3.34 31.97 44.36 Cash from Financing Activity -531.50 -33.97 -1,091.25 -245.94 -314.17 3.27 -630.34 -302.95 -248.50 -230.76 Net Cash Inflow / Outflow -816.74 1,988.42 35.84 33.88 -25.34 14.97 -5.17 -1.28 4.57 -2.43 Opening Cash & Equivalents 2,016.30 27.88 -7.96 -41.84 -16.50 -31.47 9.06 10.35 5.78 8.20 Closing Cash & Equivalent 1,199.56 2,016.30 27.88 -7.96 -41.84 -16.50 3.89 9.06 10.35 5.78

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 1,911.80 1,946.93 1,215.94 954.30 775.86 1,150.37 1,037.86 826.33 556.75 479.97 PBT 3,683.50 2,666.04 1,819.46 1,855.07 1,231.33 1,395.34 1,392.84 1,072.08 990.92 781.24 Adjustment 239.73 189.29 60.01 83.51 32.19 93.87 60.94 91.24 77.55 59.25 Changes in Working Capital -1,370.45 -264.08 -218.30 -499.84 -219.11 -37.14 -155.03 -125.55 -298.39 -186.05 Cash after chg. in Working capital 2,552.78 2,591.25 1,661.17 1,438.74 1,044.41 1,452.07 1,298.75 1,037.76 770.07 654.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -640.98 -644.32 -445.23 -484.44 -268.55 -301.70 -260.89 -211.43 -213.32 -174.47 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,194.92 75.13 -83.47 -685.40 -478.30 -1,139.60 -406.41 -520.84 -305.15 -254.54 Net Fixed Assets -691.54 -968.33 -1,302.55 -632.52 -255.54 222.19 -288.75 -286.31 -242.98 -368.08 Net Investments -72.00 971.35 974.24 -56.30 -257.57 -826.05 -77.22 -231.12 -94.07 69.23 Others -1,431.38 72.11 244.84 3.42 34.81 -535.74 -40.44 -3.41 31.90 44.31 Cash from Financing Activity -532.44 -34.89 -1,091.42 -245.94 -314.16 2.38 -631.12 -302.95 -248.50 -230.76 Net Cash Inflow / Outflow -815.56 1,987.17 41.05 22.96 -16.60 13.15 0.33 2.54 3.10 -5.33 Opening Cash & Equivalents 2,030.32 43.15 2.10 -20.86 -4.26 -17.41 17.62 15.09 11.99 17.32 Closing Cash & Equivalent 1,214.76 2,030.32 43.15 2.10 -20.86 -4.26 17.95 17.62 15.09 11.99

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 440.44 349.28 275.63 262.70 224.51 203.76 164.13 134.18 114.30 96.18 ROA 22.76% 18.84% 15.08% 15.52% 10.97% 16.92% 21.89% 17.84% 20.05% 19.15% ROE 28.13% 23.57% 19.21% 20.61% 15.30% 21.57% 28.06% 25.68% 28.34% 25.86% ROCE 35.09% 31.64% 25.23% 28.06% 21.31% 28.27% 34.53% 32.22% 35.88% 32.98% Fixed Asset Turnover 1.73 1.66 1.75 1.95 1.84 2.04 1.81 1.69 1.65 1.77 Receivable days 88.26 87.73 95.70 89.55 100.59 88.38 87.08 94.72 97.33 93.02 Inventory Days 95.85 101.33 115.82 110.13 120.67 108.57 110.86 117.81 122.46 124.00 Payable days 92.79 107.07 92.94 52.95 60.35 47.52 35.14 33.59 36.19 42.55 Cash Conversion Cycle 91.32 81.99 118.58 146.72 160.91 149.43 162.79 178.93 183.60 174.46 Total Debt/Equity 0.00 0.00 0.00 0.02 0.01 0.01 0.01 0.01 0.01 0.01 Interest Cover 2126.16 1452.86 258.94 398.66 528.86 417.89 349.89 375.24 345.75 310.56

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 441.82 350.15 275.38 262.09 223.20 201.82 161.73 131.67 111.63 94.20 ROA 22.77% 19.07% 15.11% 15.78% 11.12% 17.21% 22.49% 18.21% 19.92% 19.17% ROE 28.16% 23.90% 19.30% 21.00% 15.55% 21.98% 28.91% 26.37% 28.31% 25.99% ROCE 35.06% 32.07% 25.36% 28.50% 21.68% 28.75% 35.57% 33.06% 36.04% 33.21% Fixed Asset Turnover 1.74 1.70 1.77 1.98 1.88 2.06 1.83 1.70 1.66 1.78 Receivable days 83.26 80.66 86.18 80.35 89.33 79.19 77.83 85.12 88.42 85.08 Inventory Days 100.99 104.66 121.62 115.23 124.56 112.34 113.70 121.69 126.52 127.96 Payable days 95.88 106.32 93.73 52.21 60.15 47.14 35.06 33.55 36.16 42.47 Cash Conversion Cycle 88.36 79.00 114.07 143.37 153.75 144.39 156.47 173.26 178.78 170.58 Total Debt/Equity 0.00 0.00 0.00 0.02 0.01 0.01 0.01 0.01 0.01 0.01 Interest Cover 1842.75 1270.54 255.83 397.38 520.55 416.28 294.75 373.59 336.24 302.96

Top Investors:

sbi mutual fund

life insurance corporation of india

axis mutual fund trustee limited

government pension fund global

Annual Reports:

News Update:

Divi's Laboratories reports 19% fall in Q2 consolidated net profit
8th Nov 2022, 11:59 AM

Total consolidated income of the company marginally fall by 3.59% at Rs 1934.62 crore for Q2FY23
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback